249 related articles for article (PubMed ID: 11549342)
1. Overexpression of interleukin-6 aggravates viral myocarditis: impaired increase in tumor necrosis factor-alpha.
Tanaka T; Kanda T; McManus BM; Kanai H; Akiyama H; Sekiguchi K; Yokoyama T; Kurabayashi M
J Mol Cell Cardiol; 2001 Sep; 33(9):1627-35. PubMed ID: 11549342
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-6 and viral myocarditis: the Yin-Yang of cardiac innate immune responses.
Mann DL
J Mol Cell Cardiol; 2001 Sep; 33(9):1551-3. PubMed ID: 11549335
[No Abstract] [Full Text] [Related]
3. Protective role of interleukin-12 in viral myocarditis.
Shioi T; Matsumori A; Nishio R; Ono K; Kakio T; Sasayama S
J Mol Cell Cardiol; 1997 Sep; 29(9):2327-34. PubMed ID: 9299356
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of cyclooxygenase-2 enhances myocardial damage in a mouse model of viral myocarditis.
Takahashi T; Zhu SJ; Sumino H; Saegusa S; Nakahashi T; Iwai K; Morimoto S; Kanda T
Life Sci; 2005 Nov; 78(2):195-204. PubMed ID: 16107267
[TBL] [Abstract][Full Text] [Related]
5. Nifedipine inhibits the activation of inflammatory and immune reactions in viral myocarditis.
Liu W; Shimada M; Xiao J; Hu D; Matsumori A
Life Sci; 2009 Jul; 85(5-6):235-40. PubMed ID: 19520090
[TBL] [Abstract][Full Text] [Related]
6. Reduced-energy diet improves survival of obese KKAy mice with viral myocarditis: induction of cardiac adiponectin expression.
Kanda T; Saegusa S; Takahashi T; Sumino H; Morimoto S; Nakahashi T; Iwai K; Matsumoto M
Int J Cardiol; 2007 Jul; 119(3):310-8. PubMed ID: 17275107
[TBL] [Abstract][Full Text] [Related]
7. Cytokine profiles in heart, spleen, and thymus during the acute stage of experimental coxsackievirus B3-induced chronic myocarditis.
Schmidtke M; Glück B; Merkle I; Hofmann P; Stelzner A; Gemsa D
J Med Virol; 2000 Aug; 61(4):518-26. PubMed ID: 10897072
[TBL] [Abstract][Full Text] [Related]
8. Effect of interleukin-18 on viral myocarditis: enhancement of interferon- gamma and natural killer cell activity.
Kanda T; Tanaka T; Sekiguchi K; Seta Y; Kurimoto M; Wilson McManus JE; Nagai R; Yang D; McManus BM; Kobayashi I
J Mol Cell Cardiol; 2000 Dec; 32(12):2163-71. PubMed ID: 11112992
[TBL] [Abstract][Full Text] [Related]
9. Modification of viral myocarditis in mice by interleukin-6.
Kanda T; McManus JE; Nagai R; Imai S; Suzuki T; Yang D; McManus BM; Kobayashi I
Circ Res; 1996 May; 78(5):848-56. PubMed ID: 8620605
[TBL] [Abstract][Full Text] [Related]
10. Amiodarone inhibits interleukin 6 production and attenuates myocardial injury induced by viral myocarditis in mice.
Ito H; Ono K; Nishio R; Sasayama S; Matsumori A
Cytokine; 2002 Feb; 17(4):197-202. PubMed ID: 11991672
[TBL] [Abstract][Full Text] [Related]
11. Synergistic effects of tacrolimus and human interferon-alpha A/D in murine viral myocarditis.
Kanda T; Nagaoka H; Kaneko K; Wilson JE; McManus BM; Imai S; Suzuki T; Murata K; Kobayashi I
J Pharmacol Exp Ther; 1995 Jul; 274(1):487-93. PubMed ID: 7542339
[TBL] [Abstract][Full Text] [Related]
12. Effects of free immunoglobulin light chains on viral myocarditis.
Matsumori A; Shimada M; Jie X; Higuchi H; Groot Kormelink T; Redegeld FA
Circ Res; 2010 May; 106(9):1533-40. PubMed ID: 20360247
[TBL] [Abstract][Full Text] [Related]
13. [Protective effect and mechanism of IL-17 monoclonal antibody on mice with viral myocarditis].
Qian H; Liu L
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 May; 30(5):509-12. PubMed ID: 24796747
[TBL] [Abstract][Full Text] [Related]
14. Conditional transgenic expression of TIR-domain-containing adaptor-inducing interferon-β (TRIF) in the adult mouse heart is protective in acute viral myocarditis.
Xu Z; Desai M; Philip J; Sivsubramanian N; Bowles NE; Vallejo JG
Basic Res Cardiol; 2011 Nov; 106(6):1159-71. PubMed ID: 21956162
[TBL] [Abstract][Full Text] [Related]
15. Persistent expression of cytokines in the chronic stage of CVB3-induced myocarditis in NMRI mice.
Glück B; Schmidtke M; Merkle I; Stelzner A; Gemsa D
J Mol Cell Cardiol; 2001 Sep; 33(9):1615-26. PubMed ID: 11549341
[TBL] [Abstract][Full Text] [Related]
16. Leptin deficiency enhances myocardial necrosis and lethality in a murine model of viral myocarditis.
Kanda T; Takahashi T; Kudo S; Takeda T; Tsugawa H; Takekoshi N
Life Sci; 2004 Aug; 75(12):1435-47. PubMed ID: 15240179
[TBL] [Abstract][Full Text] [Related]
17. Treatment of virus-induced myocardial injury with a novel immunomodulating agent, vesnarinone. Suppression of natural killer cell activity and tumor necrosis factor-alpha production.
Matsui S; Matsumori A; Matoba Y; Uchida A; Sasayama S
J Clin Invest; 1994 Sep; 94(3):1212-7. PubMed ID: 8083362
[TBL] [Abstract][Full Text] [Related]
18. Immunomodulation of murine cytomegalovirus-induced myocarditis in mice treated with lipopolysaccharide and tumor necrosis factor.
Lenzo JC; Fairweather D; Shellam GR; Lawson CM
Cell Immunol; 2001 Oct; 213(1):52-61. PubMed ID: 11747356
[TBL] [Abstract][Full Text] [Related]
19. Increased severity of viral myocarditis in mice lacking lymphocyte maturation.
Kanda T; Koike H; Arai M; Wilson JE; Carthy CM; Yang D; McManus BM; Nagai R; Kobayashi I
Int J Cardiol; 1999 Jan; 68(1):13-22. PubMed ID: 10077396
[TBL] [Abstract][Full Text] [Related]
20. Exacerbation of acute viral myocarditis by tobacco smoke is associated with increased viral load and cardiac apoptosis.
Bae S; Ke Q; Koh YY; Lee W; Choi JH; Kang PM; Morgan JP
Can J Physiol Pharmacol; 2010 May; 88(5):568-75. PubMed ID: 20555426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
